πŸ‡ΊπŸ‡Έ FDA
Patent

US 10688181

Cancer treatment combinations

granted A61KA61K2039/505A61K2039/804

Quick answer

US patent 10688181 (Cancer treatment combinations) held by The Regents of the University of California expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K2039/505, A61K2039/804, A61K31/519, A61K39/39558